Navigation Links
Yale Cancer Center Joins OncLive's Strategic Alliance Partnership
Date:7/15/2014

Plainsboro, N.J. (PRWEB) July 15, 2014

OncLive® is pleased to announce that Yale Cancer Center has joined its Strategic Alliance Partnership program.

Participating in the Strategic Alliance Partnership program will enable Yale Cancer Center to work with the OncLive team to raise awareness of its efforts to deliver patient-centered care, achieve breakthrough discoveries, and train future leaders in cancer science and medicine.

Yale Cancer Center has been a National Cancer Institute (NCI)-designated comprehensive cancer center for more than 40 years, and is one of only 41 such organizations in the country. Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven have 12 multidisciplinary cancer programs, a robust portfolio of advanced clinical trials, and offer patients and their families, expert and compassionate care. Treatment at Yale increasingly places an emphasis on targeted therapies incorporating a patient’s particular cancer subtype and genetic profile.

In addition to providing cutting-edge personalized, multidisciplinary cancer care, Yale Cancer Center clinicians and scientists make significant contributions in basic and translational research. Research at Yale includes programs in developmental therapeutics, cancer genetics and genomics, molecular virology, cancer immunology, signal transduction, cancer prevention and control, and radiobiology. Yale researchers are engaged in projects designed to encourage collaborative research, such as the Cancer Biology Institute.

Mike Hennessy, Jr., Vice President of Sales and Marketing and leader of the oncology division of Intellisphere, the publisher of OncLive, said, “Yale Cancer Center has long been a pioneer in cancer treatment and drug development. We look forward to partnering with such a renowned and prestigious institution that shares our mission of supporting oncologists, nurses, and other oncology professionals in their
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test
2. Simple blood test can detect lung cancer with high sensitivity and specificity - results from large clinical validation study published in the Journal of Clinical Oncology
3. Leading Cancer Immunotherapy Biotech Startup Announces New Investments, Leadership Appointments
4. Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
5. Exosome Diagnostics and QIAGEN Expand Collaboration to Develop Non-Invasive Biofluid Diagnostic for Lung Cancer
6. Science Magazine: Cancer Immunotherapy is the Medical Breakthrough of 2013; The CBCD Highlights the Link between Immunotherapy and Microcompetition
7. A Unique Collaboration of Life Science Leaders, including the Fight Against Cancer Innovation Trust, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust, has formed Triphase Accelerator Corporation to be an Oncology Development Accele
8. Avelas Biosciences Closes $6.85 Million in Series B Financing to Advance Real-Time Cancer Visualization Technology to Clinical Proof-of-Concept
9. BerGenBio Presents Data at AACR-ISLAC Conference on the Molecular Origins of Lung Cancer
10. ReachMD Launches New Oncology Show Featuring Well-known Cancer Expert and Host, Selma Schimmel
11. Piggy-backing proteins ride white blood cells to wipe out metastasizing cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , ... June 29, 2015 , ... ... B2. Under the terms of the agreement, MediVet will acquire the rights to ... (UCMSCs). MB-007 is currently in pre-clinical development as a potential next-generation treatment for ...
(Date:6/29/2015)... BioNano Genomics, Inc., the leader in genome ... today that a collaboration led by the Icahn School ... of the first comprehensive analysis of a diploid human ... sequencing and genome mapping. This study, published today in ... the contiguous diploid human genome assembly obtained without using ...
(Date:6/29/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced ... has been awarded the Lifetime Achievement Award in the ... The Entrepreneur Of The Year Program, now ...
(Date:6/29/2015)... , June 29, 2015 According to ... RNA, XNA), by Application (Diagnostics, Therapeutics, R&D), by Technology (SELEX, ... Pharmaceutical Companies, CRO) - Global Forecast to 2020", published by ... Million by 2020 from $107.56 Million in 2015, at a ... ables and 67 F igures spread ...
Breaking Biology Technology:MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 2BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 3EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2Aptamers Market Worth $244.93 Million by 2020 2Aptamers Market Worth $244.93 Million by 2020 3Aptamers Market Worth $244.93 Million by 2020 4
... Metabolic Solutions Development Company (MSDC), a drug discovery and ... diseases, announced today that it has received a $773,000 ... conduct a pilot Phase 2a trial of MSDC-0160, MSDC,s ... with altered mitochondrial function. "This funding ...
... 2011 Reportlinker.com announces that a new market ... Biobanking: Technologies and Global Markets ... REPORT HIGHLIGHTS THIS REPORT ... biobanks by types: Population, Disease, and Private Sector ...
... and Nottingham and using nanotechnology 100,000 times smaller than the ... harnessing the vast energy of the Sun to produce clean ... Royal Society,s annual Summer Science Exhibition which opens ,today [5 ... UEA have already found a way to produce hydrogen from ...
Cached Biology Technology:Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial 2Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial 3Biobanking: Technologies and Global Markets 2Biobanking: Technologies and Global Markets 3Biobanking: Technologies and Global Markets 4Biobanking: Technologies and Global Markets 5Biobanking: Technologies and Global Markets 6Biobanking: Technologies and Global Markets 7Biobanking: Technologies and Global Markets 8Biobanking: Technologies and Global Markets 9Biobanking: Technologies and Global Markets 10Biobanking: Technologies and Global Markets 11Biobanking: Technologies and Global Markets 12Biobanking: Technologies and Global Markets 13Putting sunshine in the tank 2
(Date:6/24/2015)... , June 24, 2015 Biometry authentication ... emerging biometric password solution one face in. ... one face in, entering the expanding ... and affordable multifactor-authentication biometric answer to the password ... provided in partnership with KeyLemon, one face in ...
(Date:6/23/2015)... , June 22, 2015 ... announced the addition of the "Body-Worn Temperature ... Growth, Trends and Forecast 2014 - 2020" ... offers strategic analysis of the global body-worn temperature ... has been segmented on the basis of types, ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2
... cyclones churned across the top of the world each year, leaving ... ice in the Arctic Ocean. That,s about 40 percent more ... study of vast troves of weather data that previously were synthesized ... in the number of cyclones could be important to anyone who ...
... health professionals will attend SIR 2014, the world,s ... benefits patients with image-guided, minimally invasive medicine. ... artery embolization, renal denervation, robotics and ablative cancer ... conference showcasing current research Monday, ,March 24. ...
... Jan. 16, 2014 -- Using a camera-equipped robot to ... and engineers with the Antarctic Geological Drilling (ANDRILL) Program ... of small sea anemones were burrowed into the underside ... water like flowers on a ceiling. , "The ...
Cached Biology News:Arctic cyclones more common than previously thought 2Arctic cyclones more common than previously thought 3Arctic cyclones more common than previously thought 4Ice-loving sea anemones discovered in Antarctica 2Ice-loving sea anemones discovered in Antarctica 3
... 1. 3500 V, 400 mA, 200 W ... linear voltage ramp modes.Linear voltage ramp mode ... strips quickly without danger of overheating.Volt-hour and ... thickness, sample ionic strength, and temperature.Stores and ...
Human Aminopeptidase P1/XPNPEP1 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Template and primers for preparation of internal control spots...
Cross reactivity to St. Louis encephalitis (MSI-7) is determined by ELISA....
Biology Products: